Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131688) titled 'Tegileridine versus Sufentanil for Postoperative Analgesia in Supratentorial Craniotomy: A Randomized Controlled Trial' on Sept. 5.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Soochow University
Condition:
Supratentorial Craniotomy
Intervention:
Tegileridine Group:A single intravenous dose of tegileridine 1 mg (for patients 18-64 years of age) or 0.75 mg (for patients >= 65 years of age) at the time of dural closure
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Tegileridine Group:5...